PROGRESSIVE MULTIPLE SCLEROSIS (PMS)
Clinical trials for PROGRESSIVE MULTIPLE SCLEROSIS (PMS) explained in plain language.
Never miss a new study
Get alerted when new PROGRESSIVE MULTIPLE SCLEROSIS (PMS) trials appear
Sign up with your email to follow new studies for PROGRESSIVE MULTIPLE SCLEROSIS (PMS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could CAR T-Cells tame MS? new trial begins
Disease control Not yet recruitingThis early-stage study tests a new treatment called CABA-201 for people with multiple sclerosis (MS). It uses a patient's own immune cells, modified to target and destroy certain immune cells that may be attacking the nervous system. The main goals are to check safety and see if …
Matched conditions: PROGRESSIVE MULTIPLE SCLEROSIS (PMS)
Phase: PHASE1, PHASE2 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated May 26, 2026 08:35 UTC
-
Gene therapy trial targets tough autoimmune cases
Disease control Not yet recruitingThis early-stage study tests a new gene therapy called LVIVO-TaVec400 in people with severe autoimmune diseases like lupus, multiple sclerosis, and myasthenia gravis that have not responded to standard treatments. The main goals are to check safety and find the right dose. About …
Matched conditions: PROGRESSIVE MULTIPLE SCLEROSIS (PMS)
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 22, 2026 14:02 UTC